Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X2PR
|
|||
| Former ID |
DIB013713
|
|||
| Drug Name |
MEDI-541
|
|||
| Synonyms |
Anti-HMGB-1 MAb; HMGB-1 antagonists, Cornerstone Therapeutics; HMGB-1 antibodies, Critical Therapeutics; High mobility group box chromosomal protein 1 antagonists, MedImmune/Cornerstone Therapeutics; High mobility group box chromosomal protein 1 antagonists, MedImmune/Critical Therapeutics; HMGB-1 antagonists, MedImmune/Cornerstone Therapeutics; HMGB-1 antagonists, MedImmune/Critical Therapeutics; MGB-1 antagonists (human monoclonal antibodies), Critical Therapeutics/MedImmune
Click to Show/Hide
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
| Company |
Critical Therapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.